» Articles » PMID: 10653847

Janus Kinase 3 (Jak3) is Essential for Common Cytokine Receptor Gamma Chain (gamma(c))-dependent Signaling: Comparative Analysis of Gamma(c), Jak3, and Gamma(c) and Jak3 Double-deficient Mice

Overview
Journal Int Immunol
Date 2000 Feb 2
PMID 10653847
Citations 57
Authors
Affiliations
Soon will be listed here.
Abstract

The common cytokine receptor gamma chain (gamma(c)) is an essential receptor component for IL-2, IL-4, IL-7, IL-9 and IL-15, and thereby gamma(c)-deficient mice exhibit impaired T cell and B cell development. The Janus family tyrosine kinase 3 (Jak3) is known to be associated with gamma(c), and the reported phenotypes of gamma(c)-deficient (gamma(c)(-)) and Jak3-deficient (Jak3(-)) mice are similar, indicating that Jak3 is an essential transducer of gamma(c)-dependent signals. Nevertheless, certain differences have been suggested related to the range of actions of gamma(c) and Jak3. To clarify whether gamma(c)-dependent cytokines can partially transduce their signals without Jak3, we compared lymphocyte development in gamma(c)(-), Jak3(-), and gamma(c) and Jak3 double-deficient (gamma(c)(-)Jak3(-)) mice in the same genetic background. With the exception that T and B cells in Jak3(-) mice express high levels of gamma(c), the defects in thymocyte and peripheral T cell and B cell development are indistinguishable among gamma(c)(-), Jak3(-) and gamma(c)(-)Jak3(-) mice. Interestingly, although Bcl-2 induction was previously suggested to be Jak3-independent, IL-7 cannot induce Bcl-2 expression in CD4 single-positive (SP) thymocytes in either gamma(c)(-) or Jak3(-) mice nor can IL-7 rescue CD4 SP thymocytes from dexamethasone-induced cell death in gamma(c)(-) or Jak3(-) mice. These results indicate that Jak3 is absolutely essential for gamma(c)-dependent T cell and B cell development, and for gamma(c)-dependent prevention of thymocyte apoptosis.

Citing Articles

Targeting γc family cytokines with biologics: current status and future prospects.

Bick F, Blanchetot C, Lambrecht B, Schuijs M MAbs. 2025; 17(1):2468312.

PMID: 39967341 PMC: 11845063. DOI: 10.1080/19420862.2025.2468312.


SP140 represses specific loci by recruiting polycomb repressive complex 2 and NuRD complex.

Tamburri S, Zucchelli C, Matafora V, Zapparoli E, Jevtic Z, Farris F Nucleic Acids Res. 2024; 53(4).

PMID: 39718989 PMC: 11879014. DOI: 10.1093/nar/gkae1215.


JAK-STAT signaling in inflammation and stress-related diseases: implications for therapeutic interventions.

Sarapultsev A, Gusev E, Komelkova M, Utepova I, Luo S, Hu D Mol Biomed. 2023; 4(1):40.

PMID: 37938494 PMC: 10632324. DOI: 10.1186/s43556-023-00151-1.


Recent advances in JAK inhibitors for the treatment of metabolic syndrome.

Collotta D, Franchina M, Carlucci V, Collino M Front Pharmacol. 2023; 14:1245535.

PMID: 37701031 PMC: 10494544. DOI: 10.3389/fphar.2023.1245535.


Selectivity and Ranking of Tight-Binding JAK-STAT Inhibitors Using Markovian Milestoning with Voronoi Tessellations.

Ojha A, Srivastava A, Votapka L, Amaro R J Chem Inf Model. 2023; 63(8):2469-2482.

PMID: 37023323 PMC: 10131228. DOI: 10.1021/acs.jcim.2c01589.